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Background: Underscoring the lack of detailed report on the
molecular epidemiology of ESBL-producing Klebsiella pneumoniae
in Nigeria we evaluated the clonality, subclonal diversity, the
genetic characteristic of extended-spectrum -lactamases (ESBLs)
and virulence factor genes in K. pneumoniae isolates collected from
a tertiary hospital in Lagos, Nigeria within a period of 9 months
(November 2008-April 2009).
Methods & Materials: Clinical K. pneumoniae(n=77) were
obtained from blood culture, urine and wound samples, Identi-
ﬁcation and susceptibility testing of K. pneumoniae isolates were
performed by VITEK 2 and Etest. ESBL, other resistance (e.g. aac-
(6’)-lb-cr, qnr, tetA/L, int1) and virulence genes (magA, allS, kfuBC,
rmpA, mrkD, cf29a) were assessed by PCR and sequencing. Clonality
was determined by ERIC PCR, Diversilab and multilocus sequence
typing (MLST).
Results: Among 77K. pneumoniae isolates 30 (39%) were con-
ﬁrmed as ESBL-producers. 19 blaCTX-M-15 positive (63.3%) of the
30 isolates carried the class A chromosomal bla genes (blaSHV-1,
n=15; and blaSHV-11, n=4). Other bla genes harbored included
blaSHV-12 (n=2) and OXA-10 (n=2). An AmpC blaCMY-2 (n=1) was
found to be co-encoded with blaCTX-M-15 gene in one of the iso-
lates. Three isolates carried more than one bla genes (CTX-M-15
and SHV-12; CTX-M-15 and OXA-10; SHV-12 and OXA-10). All iso-
lates were positive for the virulence genes kfuBC and mrkD. Class
1 integron-encoding intI1 integrase was detected in 12 of the 19
ESBL-producing isolates. Plasmid mediated quinolone resistance
genes qnrB, tetA/L and aac-(6‘)-lb-cr were present among the ESBL
isolates while qnrS was detected in only 1 isolate. MLST showed
four different major sequence types (STs) among 33% of the DDST-
positive isolates which belonged to ST101, CC14 [ST15, ST14] and
ST353. Diversilab rep-PCR grouped the ST101 isolates into 2 sub-
groups.
Conclusion: This is the ﬁrst report of the emergence of blaCMY-2,
blaSHV-12 and blaOXA-10 in certain virulent K. pneumoniae isolates in
this study. Epidemiological analysis of ESBL-producing K. pneumo-
niae in Nigeria showed that a number of previously circulating K.
pneumoniae clonesmayhave acquired theblaCTX-M-15 gene, thereby
conferring resistance to multiple antibiotics while presenting new
epidemiological and clinical challenges and genotypic diversity in
Nigeria.
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In vitro activities of antimicrobial agents
against clinical isolates of Nocardia species
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Background: Nocardia species are ubiquitous in the environ-
ment and responsible for variable human infections. These species
can cause pulmonary, cutaneous, central nervous system and dis-
seminated nocardiosis. Because of a variety of susceptibilities to
different antimicrobial agents and different clinical outcomes, sus-
ceptibility testing shouldbeperformedonanyNocardia isolate. This
studywasaimed todetermineantibiotic susceptibilitiesofNocardia
species.
Methods & Materials: In this study, 45 clinical isolates of
Nocardia species were tested for antimicrobial susceptibility test-
ing. Presumptive identiﬁcation of Nocardia species was performed
according to the colony morphology on solid medium, Gram stain
appearance, and positive modiﬁed acid-fast staining. The isolates
were identiﬁed to the species level using 16S rRNA gene sequenc-
ing analysis. Susceptibility testing was determined by the broth
microdilution method using the Clinical and Laboratory Standards
Institute(CLSI) criteria which is recommended in 2011 approved
standard (M24-A2). Amikacin, ciproﬂoxacin, ceftriaxone, linezolid
and trimethoprim-sulfamethoxazole were used for the antimicro-
bial susceptibility testing.
Results: Among these 45 Nocardia species, N. cyriacigeorgica
(n:26) was the most common species, followed by N. farcinica
(n:12), N. otitidiscaviarum (n:4), N. asteroides (n:2) and N. absces-
sus (n:1). Amikacin and linezolid were the only two antimicrobials
to which all isolates were susceptible. Resistance to trimethoprim-
sulfamethoxazole (TMP-SMX), ceftriaxone and ciproﬂoxacin was
15.5%, 37.7% and 82.2% respectively.N.cyriacigeorgicawas the high-
est resistance to the ciproﬂoxacin (n:25, 96.1%) among the other
Nocardia species.
Conclusion: Nocardia species are known to vary in their sus-
ceptibilies to various antimicrobial agents. Therefore, susceptibility
testing should be performed on any Nocardia isolate considered to
be of possible clinical signiﬁcance.
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